Cue Biopharma Inc buy Jefferies Financial Group Inc.
Start price
13.03.24
/
50%
€1.97
Target price
13.03.25
€5.48
Performance (%)
-56.32%
Price
15.07.24
€0.86
Summary
This prediction is currently active. Massive losses of -56.32% have been the result for the BUY prediction by Jefferies_Financial_. This prediction currently runs until 13.03.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | - | - |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Jefferies_Financial_ for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CUE provided by MarketBeat